Introduction
The research seeks to identify ethical issues relating to advertising, marketing, intellectual property, and regulation of product safety. The paper takes a position against drug companies using Direct-to-Consumer (DTC) marketing. The paper also determines who currently regulates the compounding pharmacies regulatory scheme and what the Food and Drug Administration (FDA) should have done and if they should be given more say and power over compounding pharmacies. Again, the paper determines whether the use of Colberian intellectual property by PharmaCARE’s would be ethical in accordance with Deontology or not, virtue ethics and utilitarianism. The paper analyzes how PharmaCARE protects itself ...